Peptide Therapy Prescription in 2025: Your Safe Guide Peptides! Update as of 4.15.26 from the FDA. We will know more in July. This will allow these previously labeled category 2 research peptides to category 1 and allowable for compounding by BPC 157 has a decades long safety record with zero deaths or hospitalizations. Yet, it's unapproved because the FDA process is too expensive and the business model doesn't allow for profit. Approved drugs with How did BPC 157 become the wellness industry's star peptide? Peptides Might Be Making a Comeback In 2023, the FDA restricted 19 peptides from compounding pharmacies. Now, regulators are reviewing a possible reversal, which could allow 14 of those peptides to When will the FDA reclassify BPC 157 to Category 1 Octagon AI